Total Payments
$969.84
2024 Payments
$123.76
Companies
13
Transactions
40
Medicare Patients
631
Medicare Billing
$53,166
Payment Breakdown by Category
Food & Beverage$965.32 (99.5%)
Education$4.52 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $965.32 | 39 | 99.5% |
| Education | $4.52 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $354.92 | 16 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $128.94 | 2 | $0 (2019) |
| ABBVIE INC. | $123.76 | 1 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $66.63 | 2 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $66.35 | 5 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $60.98 | 3 | $0 (2019) |
| Alkermes, Inc. | $39.99 | 3 | $0 (2019) |
| Allergan Inc. | $31.84 | 2 | $0 (2019) |
| Indivior Inc. | $30.81 | 1 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $24.14 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $123.76 | 1 | ABBVIE INC. ($123.76) |
| 2019 | $360.21 | 15 | Neurocrine Biosciences, Inc. ($128.94) |
| 2018 | $355.23 | 17 | Otsuka America Pharmaceutical, Inc. ($208.69) |
| 2017 | $130.64 | 7 | Otsuka America Pharmaceutical, Inc. ($79.47) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $123.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2019 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $15.48 | General |
| 10/10/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: CNS | ||||||
| 08/07/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: PSYCHIATRY | ||||||
| 07/03/2019 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $30.81 | General |
| Category: BH | ||||||
| 07/03/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Schizophrenia | ||||||
| 06/05/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: PSYCHIATRY | ||||||
| 05/13/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Schizophrenia | ||||||
| 05/02/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: NEUROLOGY | ||||||
| 04/17/2019 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Schizophrenia | ||||||
| 04/04/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug), INVEGA TRINZA, INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Neuroscience | ||||||
| 02/27/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: PSYCHIATRY | ||||||
| 02/21/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $111.73 | General |
| Category: NEUROLOGY | ||||||
| 02/06/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Neuroscience | ||||||
| 11/01/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 09/19/2018 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $10.80 | General |
| Category: Schizophrenia | ||||||
| 09/05/2018 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.25 | General |
| Category: PSYCHIATRY | ||||||
| 08/22/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: CNS | ||||||
| 06/27/2018 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: PSYCHIATRY | ||||||
| 06/20/2018 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Education | In-kind items and services | $4.52 | General |
| Category: PSYCHIATRY | ||||||
| 06/06/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: NEUROSCIENCE | ||||||
| 05/07/2018 | Vanda Pharmaceuticals Inc. | Fanapt (Drug), Hetlioz | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Schizophrenia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 74 | 294 | $26,552 | $11,404 |
| 2022 | 2 | 111 | 422 | $33,967 | $12,053 |
| 2021 | 6 | 204 | 522 | $38,097 | $14,573 |
| 2020 | 6 | 242 | 704 | $45,198 | $15,136 |
Total Patients
631
Total Services
1,942
Medicare Billing
$53,166
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 44 | 124 | $21,452 | $9,991 | 46.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 30 | 170 | $5,100 | $1,413 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 45 | 101 | $17,473 | $5,393 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 48 | $8,304 | $4,459 | 53.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 33 | 273 | $8,190 | $2,200 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 47 | 84 | $14,740 | $5,890 | 40.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 14 | 18 | $3,744 | $1,987 | 53.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 33 | 47 | $4,465 | $1,804 | 40.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Facility | 2021 | 38 | 214 | $6,420 | $1,572 | 24.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 19 | $3,287 | $1,405 | 42.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 35 | 102 | $3,060 | $1,013 | 33.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 25 | 38 | $2,381 | $902.64 | 37.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 57 | 115 | $10,925 | $6,091 | 55.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Facility | 2020 | 58 | 410 | $12,300 | $3,253 | 26.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 38 | 69 | $4,347 | $1,947 | 44.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 60 | 74 | $12,802 | $1,889 | 14.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 18 | $3,114 | $1,488 | 47.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 16 | 18 | $1,710 | $468.35 | 27.4% |
About Dr. Gregory Unfried, M.D
Dr. Gregory Unfried, M.D is a Psychiatry healthcare provider based in Evansville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1194738211.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Unfried, M.D has received a total of $969.84 in payments from pharmaceutical and medical device companies, with $123.76 received in 2024. These payments were reported across 40 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($965.32).
As a Medicare-enrolled provider, Unfried has provided services to 631 Medicare beneficiaries, totaling 1,942 services with total Medicare billing of $53,166. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Evansville, IN
- Active Since 08/14/2006
- Last Updated 03/06/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1194738211
Products in Payments
- ABILIFY MAINTENA (Drug) $314.71
- VRAYLAR (Drug) $155.60
- INGREZZA (Drug) $128.94
- REXULTI (Drug) $104.61
- Fanapt (Drug) $66.35
- INVEGA SUSTENNA (Drug) $33.32
- PERSERIS (Drug) $30.81
- SPRAVATO (Drug) $27.66
- Aristada 441 mg (Drug) $27.57
- LATUDA (Drug) $24.14
- NUEDEXTA (Drug) $14.89
- NUPLAZID (Drug) $13.34
- ARISTADA (Drug) $12.42
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Evansville
Henry Kaplan, D.o, D.O
Psychiatry — Payments: $16,710
Psychiatry $16,710
Dr. Boris Vatel, M.d, M.D
Psychiatry — Payments: $3,447
Psychiatry $3,447
Willard Whitehead, Md, MD
Psychiatry — Payments: $3,314
Psychiatry $3,314
Dr. David Gray, M.d, M.D
Psychiatry — Payments: $1,388
Psychiatry $1,388
Patricia Morrison, Md, MD
Psychiatry — Payments: $431.26
Psychiatry $431.26
Mr. David Holajter, Md, MD
Psychiatry — Payments: $393.70
Psychiatry $393.70